Abstract
Background
The diagnosis of primary hyperparathyroidism (1°HP) has become more complex, as fewer patients present with classic phenotype of concomitant elevation of calcium and parathyroid hormone (PTH). In addition, the distinction between normal versus abnormal patients is challenging, with an increasing number of patients with 1°HP, who have calcium and/or PTH values within the “reference” range. Patients with “inappropriately” elevated PTH values relative to their serum calcium are considered to have 1°HP.
Methods
The study population consisted of 1753 patients with pathologically proven 1°HP and 74 healthy control patients. Nomograms were created by plotting PTH versus calcium of the two groups. The 95 % confidence zone of calcium and PTH for normal individuals was plotted and compared to patients with 1°HP.
Results
The comparison of control and disease groups showed a clear demarcation zone on the plots of calcium versus PTH. In the group of 1°HP, 70 % had classic 1°HP presentation with the concomitant elevation of both calcium (≥10.5 mg/dL) and PTH (≥65 pg/dL). 21 % had “normocalcemic” HP with calcium ≤10.5 mg/dL and PTH ≥65 pg/dL. 6 % had “normohormonal” HP with calcium ≥10.5 mg/dL and PTH ≤65 pg/dL. 3 % had both calcium and PTH within the reference range. 68.5 % of patients had single adenoma, 16 % double adenoma, and 15.5 % hyperplasia.
Conclusion
This nomogram serves as a diagnostic tool to distinguish normal patients from those with 1°HP, particularly those with atypical presentations. This recognition would permit previously observed patients to benefit from curative surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nauck MA, Meier JJ (2012) Diagnostic accuracy of an “amended” insulin-glucose ratio for the biochemical diagnosis of insulinomas. Ann Intern Med 157(11):767–775
AACE/AAES Task Force on Primary Hyperparathyroidism (2005) The american association of clinical endocrinologists and the american association of endocrine surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11(1):49–54
Siperstein A, Berber E, Barbosa GF et al (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: Analysis of 1158 cases. Ann Surg 248(3):420–428
Press DM, Siperstein AE, Berber E et al (2013) The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154(6):1232–1237 (discussion 1237–8)
Barczynski M, Branstrom R, Dionigi G, Mihai R (2015) Sporadic multiple parathyroid gland disease-a consensus report of the european society of endocrine surgeons (ESES). Langenbecks Arch Surg 400(8):887–905
Jin J, Mitchell J, Shin J, Berber E, Siperstein AE, Milas M (2012) Calculating an individual maxPTH to aid diagnosis of normocalemic primary hyperparathyroidism. Surgery 152(6):1184–1192
Wallace LB, Parikh RT, Ross LV et al (2011) The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: How low can parathyroid hormone go? Surgery 150(6):1102–1112
Dalemo S, Hjerpe P, Bostrom Bengtsson K (2006) Diagnosis of patients with raised serum calcium level in primary care, Sweden. Scand J Prim Health Care 24(3):160–165
Harvey A, Hu M, Gupta M et al (2012) A new, vitamin D-based, multidimensional nomogram for the diagnosis of primary hyperparathyroidism. Endocr Pract. 18(2):124–131
Mayer GP, Hurst JG (1978) Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. Endocrinology 102(4):1036–1042
O’Neill SS, Gordon CJ, Guo R, Zhu H, McCudden CR (2011) Multivariate analysis of clinical, demographic, and laboratory data for classification of disorders of calcium homeostasis. Am J Clin Pathol 135(1):100–107
Norman J, Goodman A, Politz D (2011) Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases. Endocr Pract. 17(3):384–394
Milas M, Wagner K, Easley KA, Siperstein A, Weber CJ (2003) Double adenomas revisited: nonuniform distribution favors enlarged superior parathyroids (fourth pouch disease). Surgery 134(6):995–1003 (discussion 1003-4)
Thier M, Nordenstrom E, Bergenfelz A, Almquist M (2015) Presentation and outcomes after surgery for primary hyperparathyroidism during an 18-year period. World J Surg 40(2):356–364
Almquist M, Bergenfelz A, Martensson H, Thier M, Nordenstrom E (2010) Changing biochemical presentation of primary hyperparathyroidism. Langenbecks Arch Surg. 395(7):925–928
Aloia JF, Feuerman M, Yeh JK (2006) Reference range for serum parathyroid hormone. Endocr Pract 12(2):137–144
Rolighed L, Rejnmark L, Sikjaer T et al (2014) Vitamin D treatment in primary hyperparathyroidism: A randomized placebo controlled trial. J Clin Endocrinol Metab 99(3):1072–1080
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Lavryk, O.A., Siperstein, A.E. Use of Calcium and Parathyroid Hormone Nomogram to Distinguish Between Atypical Primary Hyperparathyroidism and Normal Patients. World J Surg 41, 122–128 (2017). https://doi.org/10.1007/s00268-016-3716-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-016-3716-6